Efficacy of celecoxib versus ibuprofen for the treatment of patients with osteoarthritis of the knee: A randomized double-blind, non-inferiority trial

Comparative Effectiveness of Pharmacologic Interventions for Knee Osteoarthritis

(2015) Raveendhara R. Bannuru et al.   ANNALS OF INTERNAL MEDICINE

Commentary on recent therapeutic guidelines for osteoarthritis

(2015) Maurizio Cutolo et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis

(2015) Anneloes van Walsem et al.   ARTHRITIS RESEARCH & THERAPY

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation

(2014) Y Chen et al.   HEALTH TECHNOLOGY ASSESSMENT

Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999–2012

(2014) Morten Schmidt et al.   Clinical Epidemiology

Treatment Satisfaction after Switching to Another Therapy in Spanish Orthopaedic Clinic Outpatients with Knee or Hip Osteoarthritis Previously Refractory to Paracetamol

(2013) Ángel Oteo-Álvaro et al.   CLINICAL DRUG INVESTIGATION

New treatments for osteoarthritis

(2013) Elizabeth Smelter et al.   CURRENT OPINION IN RHEUMATOLOGY

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

(2013)   LANCET

Clinical management of patients with hip and knee osteoarthritis: patient satisfaction with treatment switch

(2013) Sergio Gimenez et al.   RHEUMATOLOGY INTERNATIONAL

Use of Non-Steroidal Anti-Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-Income Countries

(2013) Patricia McGettigan et al.   PLOS MEDICINE

Osteoarthritis: an update with relevance for clinical practice

(2011) Johannes WJ Bijlsma et al.   LANCET

The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review

(2011) D. Pereira et al.   OSTEOARTHRITIS AND CARTILAGE

Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis

(2009) Matthew C. Becker et al.   AMERICAN HEART JOURNAL

Pooled analysis of GI tolerability of 21 randomized controlled trials of celecoxib and nonselective NSAIDs

(2009) Liviu Niculescu et al.   CURRENT MEDICAL RESEARCH AND OPINION

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines

(2008) W. Zhang et al.   OSTEOARTHRITIS AND CARTILAGE

What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs

(2008) R Andrew Moore et al.   ARTHRITIS RESEARCH & THERAPY